22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers

Key Takeaways

  • Chronic Venous Insufficiency (CVI) stems from sustained ambulatory venous hypertension driven by primary or post-thrombotic valvular incompetence, calf muscle pump failure, and perforator reflux, which prevents normal ambulatory pressure reduction from 80-90 mmHg down to <20-30 mmHg.
  • The updated 2020 CEAP classification stratifies venous disease from C0 (no visible signs) through C1 (telangiectasias <1 mm, reticular veins 1-3 mm), C2 (varicose veins >=3 mm), C3 (edema), C4a (pigmentation/stasis eczema), C4b (lipodermatosclerosis, atrophie blanche), C4c (corona phlebectatica), C5 (healed ulcer), to C6 (active open ulcer).
  • Ankle-Brachial Pressure Index (ABPI) is mandatory before applying compression: normal is 0.90-1.20; ABPI <0.50 or absolute ankle pressure <60 mmHg is an absolute contraindication to high compression, while values >1.30 indicate arterial medial calcification (Mönckeberg sclerosis) requiring a Toe-Brachial Index (TBI).
  • High multi-layer or short-stretch compression bandaging delivering 30-40 mmHg at the ankle represents the foundational conservative therapy for venous ulcer healing, and early endovenous ablation of superficial reflux within 2 weeks accelerates ulcer healing and reduces recurrence (EVRA trial).
  • Ulcer differential diagnosis is critical: venous ulcers occupy the medial supramalleolar gaiter zone with moist granulating bases; arterial ulcers present with punched-out borders and severe rest pain relieved by dependency; Martorell ulcers arise on the posterior-lateral calf in refractory hypertension; and pyoderma gangrenosum displays violaceous undermined borders with severe pathergy.
Last updated: September 2026

22.1 Phlebology, Chronic Venous Insufficiency & Lower Extremity Ulcers

Venous Anatomy of the Lower Extremities

Understanding the multi-compartmental venous architecture of the lower limbs is essential for interpreting color duplex ultrasonography and executing interventional phlebology.

The Three Interconnected Venous Systems

  1. Deep Venous System:
    • Accompanies the major axial arterial supply and is situated deep to the muscular fascia, enclosed within muscular compartments.
    • Includes the anterior tibial, posterior tibial, and peroneal (fibular) veins of the calf, which coalesce to form the popliteal vein in the popliteal fossa. The popliteal vein ascends through the adductor canal to become the femoral vein (historically termed the superficial femoral vein, a misleading term now abandoned to avoid confusion with the superficial system), joins the profunda femoris (deep femoral) vein to form the common femoral vein, and passes beneath the inguinal ligament as the external iliac vein.
    • Within the calf musculature lie large, valve-less venous reservoirs—the soleal sinusoid veins and gastrocnemius veins—which constitute the primary muscular reservoir of the calf muscle pump.
    • The deep venous system transports 85% to 90% of venous blood returning from the lower limb back to the heart.
  2. Superficial Venous System:
    • Positioned superficial to the muscular fascia within the subcutaneous space.
    • Great Saphenous Vein (GSV / Long Saphenous Vein): Originates from the medial marginal vein of the dorsal venous arch of the foot, courses anterior to the medial malleolus, ascends the medial aspect of the calf and thigh, and terminates at the saphenofemoral junction (SFJ) where it enters the common femoral vein within the fossa ovalis. The GSV runs within a distinct anatomical fascial compartment bounded by the deep muscular fascia and the superficial saphenous fascia, producing the classic ultrasound "saphenous eye" (eye sign). Major tributaries entering near the SFJ include the superficial epigastric, superficial circumflex iliac, and external pudendal veins.
    • Small Saphenous Vein (SSV / Short Saphenous Vein): Originates from the lateral marginal vein of the foot, ascends posterior to the lateral malleolus along the posterior midline of the calf, and pierces the popliteal fascia to enter the popliteal vein at the saphenopopliteal junction (SPJ). In approximately 20% to 30% of limbs, an ascending cranial extension (the vein of Giacomini) connects the SSV to the GSV system in the posterior thigh.
  3. Perforating Vein System (Perforators):
    • Transfascial bridging veins that penetrate the rigid deep muscular fascia to connect the superficial venous network directly to the deep veins.
    • Equipped with delicate, unidirectional bicuspid valves that physiologically direct blood strictly from the superficial system into the deep system during muscular diastole.
    • Cockett Perforators (Posterior Tibial / Medial Calf Perforators): Connect the posterior arch vein (vein of Leonardo) to the posterior tibial veins in the lower and middle thirds of the medial calf. Incompetence here directly precipitates medial gaiter venous ulcers.
    • Boyd Perforators (Paratibial Perforators): Located in the proximal medial calf immediately below the medial tibial condyle, connecting the GSV to the posterior tibial veins.
    • Dodd Perforators (Femoral Canal Perforators): Located in the middle-to-distal medial thigh within Hunter's adductor canal, connecting the GSV to the femoral vein.
    • Hunterian Perforators: Situated in the proximal-to-mid medial thigh.

Pathophysiology of Chronic Venous Insufficiency (CVI)

Chronic Venous Insufficiency (CVI) encompasses the advanced cutaneous and subcutaneous manifestations of sustained venous hypertension.

Ambulatory Venous Hypertension: The Driving Hemodynamic Force

  • Under resting upright conditions, hydrostatic pressure in the ankle veins corresponds to the weight of the blood column from the right atrium down to the foot, averaging 80 to 90 mmHg.
  • In a healthy individual, walking activates the calf muscle pump:
    • During systole (muscular contraction), high intramyocardial and intramuscular pressures compress the deep soleal/gastrocnemius sinusoids, propelling blood cephalad toward the heart; competent perforator valves prevent retrograde blowout into the superficial system.
    • During diastole (muscular relaxation), deep luminal pressure drops abruptly, opening perforator valves to draw blood from the superficial veins into the deep veins while competent proximal deep valves prevent retrograde descent.
    • This cyclical pumping lowers the ambulatory venous pressure (AVP) from 90 mmHg down to <20 to 30 mmHg, and venous refilling occurs slowly via arterial inflow (>20 seconds).
  • In CVI, valvular incompetence (primary degenerative loss of valve elasticity or secondary post-thrombotic destruction following deep vein thrombosis [DVT]) or deep venous obstruction (iliac vein stenosis, May-Thurner syndrome) destroys this mechanism:
    • Muscular contraction forces blood retrograde down incompetent deep or superficial trunks or outward through incompetent perforating veins.
    • Ambulatory venous pressure fails to fall, remaining chronically elevated at 60 to 80 mmHg throughout active walking. This sustained ambulatory venous hypertension is transmitted directly into the dermal microvasculature.

Microcirculatory and Dermal Degradation Cascade

  1. Capillary Ectasia and Glomerulus-Like Formations:
    • Sustained retrograde hydrostatic pressure stretches dermal post-capillary venules and capillaries, inducing progressive elongation, tortuosity, and widening of endothelial intercellular junction gaps.
  2. Erythrocyte Extravasation & Hemosiderin Tattooing:
    • Red blood cells escape through widened endothelial pores into the papillary and reticular dermis, where they undergo mechanical lysis.
    • Extracellular hemoglobin is phagocytosed by dermal macrophages and broken down into hemosiderin.
    • Iron-laden macrophages (siderophages) persist permanently throughout the perivascular dermis, stimulating fibroblast activation and producing the characteristic golden-brown, rust-colored, or ochre hyperpigmentation known as stasis pigmentation or dermite ocre of Favre and Chaix.
  3. The Pericapillary Fibrin Cuff Hypothesis:
    • High intraluminal pressure forces high-molecular-weight plasma proteins, notably fibrinogen, into the pericapillary interstitium.
    • Extravasated fibrinogen polymerizes into dense, insoluble pericapillary fibrin cuffs surrounding dermal capillary loops.
    • While historically viewed as an absolute mechanical barrier to oxygen diffusion, modern research demonstrates that these cuffs impede physiological nutrient exchange, trap growth factors, and compromise local tissue repair.
  4. Leukocyte Trapping and Activation Hypothesis (Coleridge-Smith):
    • Reduced microcirculatory shear stress causes circulating leukocytes—principally neutrophils and monocytes/macrophages—to undergo pavementing, rolling, and firm adherence to intercellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) on activated endothelial cells.
    • Trapped leukocytes migrate into the dermis and degranulate, releasing a storm of destructive mediators:
      • Reactive Oxygen Species (ROS): Superoxide anions, hydrogen peroxide, and hydroxyl radicals driving lipid peroxidation.
      • Matrix Metalloproteinases (MMPs): Markedly upregulated MMP-1, MMP-2, MMP-9, and MMP-12 overwhelm tissue inhibitors of metalloproteinases (TIMPs), degrading collagen types I and III, elastin, and fibronectin.
      • Transforming Growth Factor-beta 1 (TGF-β1): Stimulates aberrant myofibroblast activity, driving excessive, disorganized collagen deposition in subcutaneous fat.
  5. Lipodermatosclerosis & Atrophie Blanche:
    • Lipodermatosclerosis (Hypodermitis Sclerodermiformis): Characterized by chronic lobular panniculitis, adipocyte necrosis, and dense subcutaneous fibrosis. The acute phase presents with painful, erythematous, warm, indurated plaques mimicking cellulitis. The chronic phase features circumferential, woody, board-like induration binding the dermis to underlying fascia. Because the fibrosis constricts the lower calf while proximal tissues remain edematous, the leg assumes the pathognomonic "inverted champagne bottle" or "bowling pin" contour.
    • Atrophie Blanche (Milian's White Atrophy): Represents healed cutaneous micro-infarctions resulting from local microvascular thrombosis. Clinically appears as ivory-white, porcelain-like, stellate atrophic plaques studded with hyperplastic, ectatic red capillary loops (telangiectatic petechiae) and bordered by hyperpigmentation. Atrophie blanche is intensely painful and highly susceptible to breakdown into excruciating, slow-healing micro-ulcers.

The CEAP Classification System (2020 Updated Consensus)

The international CEAP system standardizes reporting across Clinical (C), Etiological (E), Anatomical (A), and Pathophysiological (P) domains.

Clinical Classification (C-Stage)

CEAP StageClinical Findings & Morphological FeaturesClinical Significance & Management Trigger
C0No visible or palpable signs of venous disease.Symptomatic patients (C0s) complain of aching/heaviness without visible lesions.
C1Telangiectasias (<1 mm diameter) and reticular veins (1 mm to <3 mm diameter).Primarily cosmetic; sclerotherapy or transcutaneous laser.
C2Varicose veins: Subcutaneous dilated, tortuous veins >=3 mm in diameter in the upright position.Risk of thrombophlebitis; evaluation for axial reflux.
C2rRecurrent varicose veins: Recurrent varices following previous surgical or endovenous intervention.Requires detailed anatomical duplex re-mapping.
C3Venous edema: Pitting swelling of the ankle and lower leg; no trophic skin changes.Initiation of medical compression therapy (Class 2).
C4aPigmentation (hemosiderin) and/or venous stasis eczema (erythematous, scaly, pruritic stasis dermatitis).Marks structural cutaneous damage; topical steroids + compression.
C4bLipodermatosclerosis (woody subcutaneous fibrosis) and/or atrophie blanche (porcelain-white scars with petechiae).Advanced microvascular disease; high risk of imminent ulceration.
C4cCorona phlebectatica paraplantaris: Fan-shaped intradermal venules around medial/lateral malleoli.Added in 2020 revision; strong predictor of advanced CVI.
C5Healed venous ulcer: Intact skin with historical ulcer scar in typical gaiter distribution.Lifelong maintenance compression to prevent recurrence.
C6Active open venous leg ulcer: Full-thickness skin defect with active exudation in venous territory.Urgent multi-layer compression + early endovenous ablation.
C6rRecurrent active venous leg ulcer: Relapsing open ulceration despite prior healing.Re-evaluate for untreated perforator or deep venous disease.

Note on Suffixes: Each clinical stage is appended with "s" for symptomatic (e.g., pain, burning, throbbing, cramps) or "a" for asymptomatic.

Etiological, Anatomical & Pathophysiological Domains

  • Etiological (E): Ec (Congenital, e.g., Klippel-Trénaunay syndrome), Ep (Primary cause, degenerative wall weakness), Es (Secondary cause, e.g., post-thrombotic syndrome after DVT, trauma), En (No venous etiology identified).
  • Anatomical (A): As (Superficial veins: GSV, SSV), Ad (Deep veins: femoral, popliteal, tibial), Ap (Perforating veins), An (No venous location identified).
  • Pathophysiological (P): Pr (Reflux), Po (Obstruction), Pr,o (Combined reflux and obstruction), Pn (No venous pathophysiology identifiable).

Differential Diagnosis of Lower Extremity Ulcers

Accurate differentiation between venous, arterial, neuropathic, arteriolosclerotic, and autoinflammatory ulcers is essential in specialist practice.

Comprehensive Ulcer Differential Diagnosis Matrix

FeatureVenous Leg Ulcer (~70%)Arterial / Ischemic Ulcer (~10-15%)Neuropathic / Diabetic Ulcer (~5-10%)Martorell Hypertensive Ulcer (~1-2%)Pyoderma Gangrenosum (~1%)
Primary Anatomical LocationMedial supramalleolar region ("gaiter area"); rarely lateral malleolus.Distal pressure sites: tips of toes, interdigital spaces, heel, lateral malleolus.Plantar pressure points: Metatarsal heads, plantar hallux, calcaneus.Lateral, anterolateral, or posterior lower calf; middle third of leg.Lower extremities (pretibial), peristomal, surgical scars, trunk.
Border & Edge MorphologyIrregular, sloping, shallow edges; flat margins."Punched-out", sharply circumscribed, steep vertical walls.Punched-out base surrounded by exuberant hyperkeratotic callus.Angulated, irregular, with a violaceous or purpuric halo and necrotic rim.Violaceous to gunmetal-blue, ragged, undermined borders.
Ulcer Base & ExudateMoist, highly exudative; healthy red granulation or yellow fibrinous slough.Dry, pale, gray, poorly vascularized; black necrotic dry eschar.Granular or pale base; variable depth, often exposing tendon/bone (probe-to-bone test).Superficial-to-deep necrotic black eschar with scanty exudate.Purulent, cribriform (sieve-like) base with sterile liquefactive necrosis.
Pain Characteristics & Positional EffectsMild-to-moderate dull ache or heaviness; relieved by leg elevation and compression.Severe, excruciating rest pain (worse at night); exacerbated by elevation, relieved by dependency (hanging foot over bed).Typically painless due to sensory neuropathy; burning paresthesias may precede.Excruciating, agonizing ischemic pain; completely disproportionate and opioid-resistant.Severe, throbbing pain; exquisitely tender to minimal palpation.
Surrounding Cutaneous FindingsHemosiderin pigmentation, stasis eczema, lipodermatosclerosis, atrophie blanche, edema.Cold, pale or cyanotic skin; hairless shiny extremity; thickened dystrophic nails; dependent rubor.Warm extremity, dry anhidrotic skin (autonomic failure), claw toes, Charcot arthropathy.Mild surrounding skin changes; severe long-standing systemic hypertension.Surrounding erythema, pustules; marked pathergy (worsens with trauma/needles).
Vascular Examination & PulsesNormal peripheral pulses (unless mixed disease); normal capillary refill.Diminished or absent dorsalis pedis / posterior tibial pulses; capillary refill >3-4 sec.Pulses usually palpable and bounding (arteriovenous shunting); unless neuro-ischemic.Pulses normal and palpable (disease affects subcutaneous arterioles, not large arteries).Normal pulses; systemic autoinflammatory association (IBD, rheumatoid arthritis).
ABPI ProfileNormal (0.90 to 1.20).Decreased (<0.80); severe disease <0.50.Normal (0.90-1.20) or falsely elevated (>1.30 due to Mönckeberg sclerosis).Normal (0.90 to 1.20); large axial arteries are patent.Normal (0.90 to 1.20).
Histopathological HallmarkDilated capillaries, pericapillary fibrin, dermal hemosiderin, fibrosis.Ischemic epidermal necrosis without specific vasculitis.Hyperkeratosis, neurotrophic ulceration; osteomyelitis if deep.Subcutaneous arteriolosclerosis: Marked medial hypertrophy, intimal hyalinosis, luminal occlusion.Neutrophilic dermatosis: Dense sterile neutrophilic dermal infiltration and tissue necrosis.
Definitive ManagementMulti-layer compression (30-40 mmHg) + superficial endovenous ablation.Urgent revascularization (angioplasty/bypass); COMPRESSION IS CONTRAINDICATED.Offloading (total contact casting), aggressive callus debridement, glycemic control.Strict BP control, pain control, surgical necrosectomy + split-thickness skin graft.Systemic immunosuppression (corticosteroids, cyclosporine, biologics); DEBRIDEMENT CONTRAINDICATED.

Diagnostic Evaluation: ABPI and Duplex Ultrasonography

Ankle-Brachial Pressure Index (ABPI) Protocol & Interpretation

The ABPI is the mandatory, non-negotiable screening test required before prescribing any lower extremity compression bandaging.

  • Measurement Technique:
    • The patient rests in the supine position for at least 10 to 15 minutes.
    • An appropriately sized blood pressure cuff is placed around the upper arm, and a 5 to 8 MHz handheld continuous-wave Doppler probe is positioned over the brachial artery to detect systolic flow.
    • Systolic blood pressure is recorded in both arms, and the higher of the two brachial pressures is selected as the systemic denominator.
    • The cuff is applied immediately above the ankle, and Doppler signals are identified over the dorsalis pedis (DP) and posterior tibial (PT) arteries in each leg.
    • The highest systolic pressure detected at the ankle (either DP or PT) serves as the numerator for that limb.
  • Formula: ABPI=Highest Systolic Ankle Pressure (DP or PT)Highest Systolic Brachial Pressure (Right or Left Arm)\text{ABPI} = \frac{\text{Highest Systolic Ankle Pressure (DP or PT)}}{\text{Highest Systolic Brachial Pressure (Right or Left Arm)}}

ABPI Clinical Stratification Guide

  • 0.90 to 1.20 (Normal Perfusion): Absence of significant arterial stenosis. Safe for standard high-compression bandaging (30 to 40 mmHg at the ankle).
  • 0.80 to 0.89 (Mild Arterial Disease): Safe for standard multi-layer or modified compression with close surveillance.
  • 0.50 to 0.79 (Moderate Peripheral Arterial Disease [PAD]): Arterial inflow is compromised. Standard 40 mmHg compression is contraindicated. Only reduced, modified light compression (maximum 15 to 20 mmHg) may be applied by experienced personnel under direct vascular supervision.
  • <0.50 or Absolute Ankle Pressure <60 mmHg (Severe Arterial Disease / Critical Limb Ischemia): ALL COMPRESSION IS STRICTLY CONTRAINDICATED. Applying compression will precipitate irreversible tissue infarction and gangrene. Immediate vascular surgical evaluation for urgent arterial revascularization is mandatory.
  • >1.30 (Incompressible Calcified Arteries): Caused by Mönckeberg medial calcific sclerosis, heavily prevalent in patients with long-standing diabetes mellitus and end-stage renal disease (ESRD). The arterial wall fails to collapse under cuff pressure, yielding an artifactually high reading that obscures severe ischemia. In this setting, the ABPI is invalid; mandatory next steps include measuring the Toe-Brachial Index (TBI) using digital plethysmography (normal TBI >0.70; severe ischemia <0.50) or recording Doppler arterial velocity waveforms.

Duplex Ultrasonography: The Gold Standard in Phlebology

Color duplex ultrasound combines anatomical B-mode imaging with pulsed-wave Doppler to evaluate luminal patency and valvular competence.

  • Patient Positioning: The patient must be examined in the upright (standing) position with body weight shifted to the contralateral limb, allowing physiological hydrostatic venous distension.
  • Provocative Maneuvers: Valvular competence is tested by distal manual compression followed by rapid release, or by using a pneumatic cuff rapid-deflator. For the SFJ and common femoral vein, a Valsalva maneuver is utilized.
  • Standard Pathological Reflux Thresholds (Cut-Off Times):
    • Superficial Venous Trunks (GSV, SSV, accessories): Pathological reflux is defined as retrograde flow duration >0.5 seconds (>500 ms) upon release of distal compression.
    • Deep Venous System (Femoral, Popliteal veins): Pathological reflux is defined as retrograde flow duration >1.0 second (>1000 ms).
    • Perforating Veins: Pathological outward (deep-to-superficial) reflux is defined as flow duration >0.35 to 0.5 seconds, particularly when accompanied by an anatomical perforator diameter >=3.5 mm.

Compression Therapy: Science, Systems & Prescribing Rules

Compression therapy is the undisputed cornerstone of conservative management for chronic venous insufficiency and venous ulceration.

Physiological Mechanisms of External Compression

  1. Hemodynamic Optimization: Reduces luminal diameter of superficial and deep veins, re-approximating valve leaflets and restoring competence to borderline-incompetent valves.
  2. Capillary Decompression: Transmits external counter-pressure to interstitial tissue, attenuating capillary leakage, accelerating microvascular red blood cell velocity, and rapidly resolving interstitial edema.
  3. Biochemical Modulation: Downregulates inflammatory cytokines (TNF-α, IL-1β) and matrix metalloproteinases (MMP-2, MMP-9), promotes local fibrinolysis via tissue plasminogen activator (tPA) release, and restores microvascular endothelial function.

Compression Bandaging Systems

  • Multi-Layer Elastic Bandages (e.g., 4-Layer System):
    • Consist of an orthopaedic padding layer, a crepe bandage, an elastic compressive bandage, and a cohesive outer wrap.
    • Delivers high sustained resting pressure (~40 mmHg at the ankle), graduated to ~17 mmHg at the upper calf.
    • Ideal for immobile or bedridden patients because elastic fibers maintain resting pressure without requiring calf muscle contraction.
  • Short-Stretch (Inelastic) Bandages:
    • Composed of 100% cotton fibers with low extensibility (<100% stretch).
    • Generate low resting pressure (comfortable while lying down at night) but produce high dynamic working pressure during walking when calf muscles expand against the rigid, unyielding bandage.
    • Highly effective for ambulatory patients with competent calf muscle pumps; requires frequent re-wrapping as limb edema subsides.
  • Medical Compression Stockings (European Standard RAL-GZ 387):
    • Class 1 (18 to 21 mmHg): Mild CVI, reticular veins, pregnancy prophylaxis, mild edema.
    • Class 2 (23 to 32 mmHg): Moderate CVI, pronounced varicose veins, post-sclerotherapy, healed venous ulcer maintenance (CEAP C3–C5).
    • Class 3 (34 to 46 mmHg): Severe CVI, severe lipodermatosclerosis, active/recurrent ulceration, secondary lymphedema (CEAP C4b–C6).
    • Class 4 (>49 mmHg): Severe elephantiasis, irreversible lymphatic edema.

Absolute and Relative Contraindications to High Compression

  • Absolute Contraindications:
    1. Severe Peripheral Arterial Disease (ABPI <0.50 or absolute ankle systolic pressure <60 mmHg).
    2. Decompensated / Acute Congestive Heart Failure (NYHA Class IV); sudden mobilization of large volumes of peripheral edema into the central circulation can trigger acute pulmonary edema.
    3. Phlegmasia cerulea dolens (acute massive deep and collateral venous thrombosis requiring immediate emergency vascular intervention).
    4. Severe septic cellulitis / septic phlebitis.
    5. Severe advanced peripheral sensory neuropathy (risk of unnoticed pressure ulceration and necrosis).
  • Relative Contraindications (Require Reduced / Modified Pressure ~20 mmHg):
    1. Mild-to-moderate PAD with ABPI 0.50 to 0.80.
    2. Well-controlled moderate congestive heart failure under cardiology co-management.

Modern Interventional Phlebology

Surgical high ligation and stripping of the GSV (the Babcock procedure) has been largely replaced in modern European guidelines by minimally invasive endovenous modalities.

The EVRA Trial (Early Venous Reflux Ablation)

  • The landmark EVRA trial (Gohel et al., New England Journal of Medicine, 2018) established that early endovenous ablation of superficial venous reflux within 2 weeks of presentation significantly accelerates venous ulcer healing (median time to healing 56 days vs 82 days with deferred ablation) and reduces ulcer recurrence rates compared to compression therapy alone.
  • Clinical Takeaway: Active venous ulceration (CEAP C6) is an indication for early procedural intervention, not a contraindication to surgery.

Interventional Modalities

  1. Endovenous Thermal Ablation:
    • Endovenous Laser Ablation (EVLA): Utilizes wavelengths targeting water or hemoglobin (e.g., 1470 nm diode laser delivered through radial-emitting optical fibers). Laser energy heats the venous blood and endothelium, denaturing vessel wall collagen and inducing irreversible fibrotic shrinkage and occlusion.
    • Radiofrequency Ablation (RFA): Delivers thermal energy via a bipolar catheter heating the vein wall to 120°C in sequential segments.
    • Requirement for Tumescent Local Anesthesia (TLA): Mandatory for all thermal ablation procedures. A large volume of diluted lidocaine with adrenaline and bicarbonate is infused into the perivenous saphenous space under ultrasound guidance. TLA provides: (a) local anesthesia, (b) a protective heat sink preventing thermal injury to adjacent cutaneous sensory nerves (saphenous nerve, sural nerve) and skin, and (c) vein compression against the catheter to ensure optimal thermal transfer.
  2. Ultrasound-Guided Foam Sclerotherapy (UGFS):
    • A liquid detergent sclerosant—most commonly polidocanol or sodium tetradecyl sulfate (STS)—is mixed with a gas (sterile air or a physiological CO₂/O₂ mixture) using the Tessari double-syringe method (1 part liquid to 4-5 parts gas through a 3-way stopcock) to generate a stable microfoam.
    • Mechanism: The microfoam displaces intravascular blood, ensuring prolonged, undiluted contact with the vascular endothelium. This extracts endothelial surface lipids, strips the cell membrane, and exposes subendothelial collagen, resulting in acute vasospasm, occlusive thrombosis, and eventual fibrotic transformation into a fibrous cord.
    • Indications: Tortuous varicose tributaries, recurrent varices (C2r), incompetent perforator veins, and venous vascular malformations.
    • Transient Complications: Cutaneous hyperpigmentation (hemosiderin entrapment requiring microthrombectomy), matting (tiny telangiectasias), and transient visual scotomas or migraine-like aura (mediated by transient microemboli crossing a patent foramen ovale [PFO]).
Loading diagram...
Pathophysiological Cascade and Diagnostic-Therapeutic Algorithm in Venous Disease
Test Your Knowledge

A 68-year-old female presents with a 4-month history of an irregularly bordered, shallow, exudative ulcer over the left medial malleolus with surrounding lipodermatosclerosis and hemosiderin pigmentation. Handheld Doppler examination demonstrates a right brachial systolic pressure of 140 mmHg, left brachial systolic pressure of 145 mmHg, and a left dorsalis pedis systolic pressure of 130 mmHg. Duplex ultrasound confirms saphenofemoral junction incompetence with reflux lasting 1.8 seconds. What is the calculated Ankle-Brachial Pressure Index (ABPI) and the appropriate initial therapeutic management?

A
B
C
D
Test Your Knowledge

Which of the following pathological thresholds on duplex ultrasonography definitively establishes the diagnosis of clinically significant venous reflux in the Great Saphenous Vein (GSV) and the deep femoral vein, respectively?

A
B
C
D
Test Your Knowledge

A 72-year-old male with long-standing poorly controlled type 2 diabetes mellitus and chronic kidney disease presents with a 2-month history of an ulcer over the medial ankle. Handheld Doppler examination demonstrates an ankle systolic pressure of 210 mmHg and a brachial systolic pressure of 140 mmHg, resulting in an ABPI of 1.50. What is the physiological mechanism explaining this ABPI value, and what is the mandatory next diagnostic step before applying compression therapy?

A
B
C
D
Test Your Knowledge

A 62-year-old female with refractory severe arterial hypertension presents with an exquisitely painful, rapidly expanding ulcer over the posterior lower calf. The ulcer exhibits a violaceous halo, necrotic black edges, and superficial slough. Morphine fails to control her pain. A deep incisional biopsy including subcutaneous tissue demonstrates severe arteriolar medial hypertrophy, intimal hyalinosis, and luminal obliteration without vasculitic leukocytoclasia. What is the definitive diagnosis and primary management?

A
B
C
D